Phase Ib trial of tasurgratinib (E7090) with or without endocrine therapies for patients (pts) with ER+, HER2− recurrent/metastatic breast cancer (BC) after receiving a CDK4/6 inhibitor. Outcomes of ...
Microtissues (MTs) created from adipose-derived stem cells (ADSCs) could go some way to overcoming issues associated with the single-cell injection strategy in erectile dysfunction (ED) therapy, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results